150 related articles for article (PubMed ID: 15043468)
1. Immunohistochemical analysis of lung carcinomas with pure or partial bronchioloalveolar differentiation.
Sarantopoulos GP; Gui D; Shintaku P; Hong L; Wang YY; Yap CS; Fishbein MC
Arch Pathol Lab Med; 2004 Apr; 128(4):406-14. PubMed ID: 15043468
[TBL] [Abstract][Full Text] [Related]
2. Mucinous and nonmucinous bronchioloalveolar adenocarcinomas have distinct staining patterns with thyroid transcription factor and cytokeratin 20 antibodies.
Goldstein NS; Thomas M
Am J Clin Pathol; 2001 Sep; 116(3):319-25. PubMed ID: 11554157
[TBL] [Abstract][Full Text] [Related]
3. Bronchioloalveolar differentiation in lung adenocarcinomas.
Dukić N; Babić B; Eri Z; Zec D; Lovrenski A; Kolarov V
Bosn J Basic Med Sci; 2011 Nov; 11(4):248-52. PubMed ID: 22117833
[TBL] [Abstract][Full Text] [Related]
4. Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma.
Shah RN; Badve S; Papreddy K; Schindler S; Laskin WB; Yeldandi AV
Hum Pathol; 2002 Sep; 33(9):915-20. PubMed ID: 12378517
[TBL] [Abstract][Full Text] [Related]
5. Expression of thyroid transcription factor-1, cytokeratin 7, and cytokeratin 20 in bronchioloalveolar carcinomas: an immunohistochemical evaluation of 67 cases.
Lau SK; Desrochers MJ; Luthringer DJ
Mod Pathol; 2002 May; 15(5):538-42. PubMed ID: 12011259
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of cytokeratins 7 and 20 and thyroid transcription factor-1 in bronchioloalveolar carcinoma: an immunohistochemical study in fine-needle aspiration biopsy specimens.
Simsir A; Wei XJ; Yee H; Moreira A; Cangiarella J
Am J Clin Pathol; 2004 Mar; 121(3):350-7. PubMed ID: 15023039
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of Cdx2 in separating mucinous bronchioloalveolar adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma.
Saad RS; Cho P; Silverman JF; Liu Y
Am J Clin Pathol; 2004 Sep; 122(3):421-7. PubMed ID: 15362373
[TBL] [Abstract][Full Text] [Related]
8. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
[TBL] [Abstract][Full Text] [Related]
9. Ovarian metastasis originating from bronchioloalveolar carcinoma: a rare presentation of lung cancer.
Yeh KY; Chang JW; Hsueh S; Chang TC; Lin MC
Jpn J Clin Oncol; 2003 Aug; 33(8):404-7. PubMed ID: 14523061
[TBL] [Abstract][Full Text] [Related]
10. Bronchioloalveolar carcinoma of mixed mucinous and nonmucinous type: immunohistochemical studies and mutation analysis of the p53 gene.
Sato K; Ueda Y; Shikata H; Katsuda S
Pathol Res Pract; 2006; 202(10):751-6. PubMed ID: 16959434
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of thyroid transcription factor-1 expression in both early-stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung.
Saad RS; Liu YL; Han H; Landreneau RJ; Silverman JF
Hum Pathol; 2004 Jan; 35(1):3-7. PubMed ID: 14745718
[TBL] [Abstract][Full Text] [Related]
12. Bronchioloalveolar carcinoma (lepidic growth) component is a more useful prognostic factor than lymph node metastasis.
Anami Y; Iijima T; Suzuki K; Yokota J; Minami Y; Kobayashi H; Satomi K; Nakazato Y; Okada M; Noguchi M
J Thorac Oncol; 2009 Aug; 4(8):951-8. PubMed ID: 19543119
[TBL] [Abstract][Full Text] [Related]
13. Adenocarcinomas with prominent lepidic spread: retrospective review applying new classification of the American Thoracic Society.
Xu L; Tavora F; Battafarano R; Burke A
Am J Surg Pathol; 2012 Feb; 36(2):273-82. PubMed ID: 22198010
[TBL] [Abstract][Full Text] [Related]
14. SCCRO expression correlates with invasive progression in bronchioloalveolar carcinoma.
Sarkaria IS; Pham D; Ghossein RA; Talbot SG; Hezel M; Dudas ME; Ebright MI; Chuai S; Memoli N; Venkatraman ES; Miller VA; Kris MG; Zakowski MF; Rusch VW; Singh B
Ann Thorac Surg; 2004 Nov; 78(5):1734-41. PubMed ID: 15511464
[TBL] [Abstract][Full Text] [Related]
15. Primary signet-ring cell carcinoma of lung: immunohistochemical study and comparison with non-pulmonary signet-ring cell carcinomas.
Merchant SH; Amin MB; Tamboli P; Ro J; Ordóñez NG; Ayala AG; Czerniak BA; Ro JY
Am J Surg Pathol; 2001 Dec; 25(12):1515-9. PubMed ID: 11717541
[TBL] [Abstract][Full Text] [Related]
16. Thyroid transcription factor-1 and cytokeratins 7 and 20 in pulmonary and breast carcinoma.
Harlamert HA; Mira J; Bejarano PA; Baughman RP; Miller MA; Whitsett JA; Yassin R
Acta Cytol; 1998; 42(6):1382-8. PubMed ID: 9850647
[TBL] [Abstract][Full Text] [Related]
17. Minimally invasive adenocarcinomas of the lung.
Dacic S
Adv Anat Pathol; 2009 May; 16(3):166-71. PubMed ID: 19395880
[TBL] [Abstract][Full Text] [Related]
18. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors.
Cai YC; Banner B; Glickman J; Odze RD
Hum Pathol; 2001 Oct; 32(10):1087-93. PubMed ID: 11679943
[TBL] [Abstract][Full Text] [Related]
19. Bronchioloalveolar carcinoma: a review of current concepts and evolving issues.
Yousem SA; Beasley MB
Arch Pathol Lab Med; 2007 Jul; 131(7):1027-32. PubMed ID: 17616987
[TBL] [Abstract][Full Text] [Related]
20. CD44v6 expression in primary bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma.
Ohori NP; Coppola D; Landreneau RJ
Mod Pathol; 1996 May; 9(5):507-12. PubMed ID: 8733765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
